Cancer Committee/Care Quality
Your care is in the best of hands. Our Cancer Committee leads the cancer program by setting goals, monitoring cancer related activity, evaluating patient outcomes, and improving patient care. We offer weekly clinical cancer conferences that provide a forum for patient consultation and contribute to physician and staff education. We also maintain an ongoing quality improvement program, which is the mechanism for evaluating and improving patient outcomes. In addition, we have a cancer registry and database that is the basis for monitoring the quality of care and cancer statistics.
Cancer Committee Members
-
Nicolas Kummer, MD (radiation oncologist and chair of the Cancer Committee)
-
Anna Hansen, MD (diagnostic radiologist)
-
Cate Straub, MD (surgeon and cancer liaison physician)
-
Ensi Voshtina, DO (medical director of oncology)
-
Jackie Zarate (clinical research coordinator)
-
Joan Rimes (cancer registry quality coordinator)
-
Kelly Nash, MSW (social worker and psychosocial services coordinator)
-
Kim Fischer (quality improvement coordinator)
-
Lori Allen (oncology nurse manger)
-
Maggie Ellings, DNP (survivorship program coordinator)
-
Paul Furmanczyk, MD (pathologist)
-
Rachelle Boyd (tumor registrar and cancer conference coordinator)
-
Spencer Green (cancer program administrator)
Clinical Cancer Conference
Also known as the Tumor Board, these weekly conferences are held to discuss challenging cancer diagnoses in a multispecialty team setting. Every week, oncologists, radiation oncologists, surgeons, pathologists, radiologists, primary care physicians and other relevant specialty medicine physicians come together to discuss the patient’s care and treatment plan. Nursing staff, pharmacists, research and other allied health professionals are also in attendance. We also have the capability of involving our physicians in Moses Lake, Omak and other outreach clinics.
The Clinical Cancer Conference team carefully reviews each patient’s cancer and clinical history, pathology/radiology findings and surgical details if applicable. The most current diagnostic and treatment pathways as well as available clinical research trials and cancer staging are discussed. A plan of action and recommendations by the group are submitted by the coordinator to each member of the patient’s cancer-care team.
Reports
- 2018 Oncology Annual Report
- 2017 Oncology Annual Report
- 2016 Oncology Annual Report
- 2015 Oncology Annual Report